Arkolith/Insider Trading/HALO/Form 4

Torley Helen

PRESIDENT AND CEO, DirectorHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed Apr 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$635K
Net Open-Market Flow
-$635K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)10K$12.07$121K778K
Apr 6, 2026Sell(S)6K$63.14$373K772K
Apr 6, 2026Sell(S)4K$64.02$262K768K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)10K$12.07$121K102K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML